Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Citigroup Maintains Buy on Universal Health Servs, Raises Price Target to $193

Author: Benzinga Newsdesk | February 29, 2024 01:13pm
Citigroup analyst Jason Cassorla maintains Universal Health Servs (NYSE:UHS) with a Buy and raises the price target from $170 to $193.

Posted In: UHS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist